On the horizon: Immunotherapy strategies for relapsed/refractory high-risk neuroblastoma (on-demand)

On the horizon: Immunotherapy strategies for relapsed/refractory high-risk neuroblastoma (on-demand)
December 8, 2020 ology
Current Status
Not Enrolled
Price
Free
Get Started

This webcast, On the horizon: Immunotherapy strategies for relapsed/refractory high-risk neuroblastoma, was originally presented as a live virtual, CME-certified 90-minute satellite symposium at the SIOP 2020 Virtual Congress.

This educational activity is accredited for physician continuing medical education (AMA) and for continuing nursing education (ANCC-APRN) by the Postgraduate Institute for Medicine. A statement of credit will be issued only upon receipt of a completed activity evaluation form.

This activity is supported by an independent educational grant from Y-mAbs Therapeutics, Inc.